BY MOIRA TAN
JANUARY 20, 2021
In this op-ed, Moira Tan, a 23-year-old Washington, D.C.-based reproductive justice organizer and legal scholar, explains how access to the abortion pill can help young people. She is a member of the Young Womxn of Color 4 Reproductive Justice Leadership Council and a volunteer with Collective Action for Safe Spaces DC.
Nearly 50 years after the Supreme Court decided Roe v. Wade (1973), challenges to abortion continue to deluge the political landscape. From Louisiana to Kentucky to Colorado and Oregon, none of us young people organizing for abortion access in our communities are left unscathed by the relentless attacks on the constitutionally-affirmed procedure. There are unnecessary waiting periods, the proliferation of deceitful clinics, age restrictions, and more, with hundreds of bills and regulations introduced every year at the state and federal levels.
The Supreme Court ruling on Tuesday puts abortion patients’ health at risk.
Jan 14, 2021
Rewire News Group Staff
The Supreme Court sided with the Trump administration Tuesday in a ruling that puts abortion patients’ health at risk—the first abortion-related ruling with Amy Coney Barrett on the bench.
The decision in FDA v. ACOG reinstates a federal policy that requires medication abortion patients to pick up their abortion medications in person. Providers had challenged the policy because of the pandemic and a federal court had blocked it. The ruling puts that policy back in place.
The court issued its first abortion decision since Amy Coney Barrett was confirmed.
By LEAH LITMAN
JAN 14, 2021
On Tuesday evening, the Supreme Court released its first abortion decision since Senate Republicans confirmed Amy Coney Barrett as Ruth Bader Ginsburg’s successor. The court’s unexplained, unsigned order allows the government to restrict access to the abortion pill. It also provides a strong signal that the new court is willing to indulge restrictions on abortion, even though it did not bother to explain why. Some may be inclined to write off the court’s decision since the incoming Biden administration could change the specific regulation at issue in the case, which required women to pick up mifepristone in person from a medical facility. But the decision serves as a standing invitation to states to impose yet more draconian restrictions on abortion.
Abortions have been available by mail during coronavirus. Not anymore.
Jan. 13, 2021
Julie Amaon wanted to make the process as easy as possible. Her organization — Just the Pill — began facilitating abortions by mail in October. After they scheduled a call with a doctor, patients in Minnesota would typically receive their pill in the mail within 72 hours. Amaon, a family medicine doctor and medical director for Just the Pill, always followed up with a care package: Oreos, sanitary pads and a bag of peach mango herbal tea.
The entire operation screeched to a halt Tuesday night, when the Supreme Court lifted a national injunction that allowed women to access the abortion pill remotely during the coronavirus pandemic. Since July, patients had been able to request an abortion pill without ever setting foot in a clinic or a doctor’s office, an accommodation instituted to protect patients from the virus.
In its First Abortion Decision Since Justice Barrett’s Confirmation, the Court Allowed the Trump Administration to Subject Abortion Patients to Needless Covid-19 Risk
JANUARY 12, 2021
American Civil Liberties Union
WASHINGTON — In its first ruling on abortion with Justice Amy Coney Barrett on the bench, the Supreme Court today reinstated a federal policy that requires patients seeking a medication used for early abortion care to incur unnecessary COVID-19 risks by traveling to a health center for the sole purpose of picking up a pill and signing a form.
The U.S. Food and Drug Administration (FDA) policy requires patients seeking mifepristone to pick up the pill in person at a hospital, clinic, or medical office, even when the patient has already been evaluated by a clinician using telehealth or at a prior in-person visit and will be receiving no medical services at the time. During the pandemic, this travel exposes patients to needless COVID-19 risks relating to transportation, childcare, and other interpersonal contact. With today’s decision from the Supreme Court, the in-person pill pick-up requirement will go back into effect immediately.
In their first abortion case since Justice Amy Coney Barrett joined the court, the justices reinstated a requirement that women seeking medication abortions pick up a pill in person.
By Adam Liptak, New York Times
Jan. 12, 2021
WASHINGTON — In the Supreme Court’s first ruling on abortion since the arrival of Justice Amy Coney Barrett, the court on Tuesday reinstated a federal requirement that women seeking to end their pregnancies using medications pick up a pill in person from a hospital or medical office.
The court’s brief order was unsigned, and the three more liberal justices dissented. The only member of the majority to offer an explanation was Chief Justice John G. Roberts Jr., who said the ruling was a limited one that deferred to the views of experts.
By Carrie N. Baker
The COVID-19 pandemic is transforming many aspects of our lives, and
abortion is no exception. Telemedicine is expanding access to abortion health
care in ways that are likely to persist long after the pandemic is over.
Telemedicine abortion combines medication abortion — which uses pills to end a
pregnancy — and telemedicine — which allows health providers to supervise the
use of abortion pills via videoconferencing or telephone consultations.
Here Are 2 Things the Biden Administration Can Do to Extend Access
BY RACHEL REBOUCHÉ
DECEMBER 22, 2020
All eyes are on new appointments to President-elect Joe Biden’s Administration, with great speculation about which policies those appointees will change first. In particular, reproductive-rights supporters wonder what protection the Biden Administration can provide for abortion now that the Supreme Court has six votes to overturn or to further eviscerate the core holding of Roe v. Wade. But the Supreme Court is not the only forum for protecting abortion access, and new leadership for executive agencies matters more than has been popularly discussed. The Biden Administration could take two related actions–one right after taking office and one a few months later–that would help provide early and safe abortion to many thousands of people.
The Court’s new majority has its first chance to take a shot at Roe v. Wade.
By Ian Millhiser
Dec 17, 2020
Last October, the Supreme Court handed down a fairly surprising order in an abortion case.
FDA v. American College of Obstetricians and Gynecologists concerns whether patients should have an easier time obtaining a pill used in medication abortions while the Covid-19 pandemic is still raging, but the Trump administration saw in the case an opportunity to drastically roll back abortion rights. One of the administration’s arguments could force abortion patients to have unnecessary surgeries instead of receiving a far less invasive medication abortion, and it could potentially deny abortions to many people altogether.
Abortion drugs administered as early as 28 days after a woman’s last period can offer comfort in uncertainty to those who want it.
By Patrick Adams
Dec. 3, 2020
The pregnancy test is one of the most ubiquitous home health care products in America. What resembled a child’s chemistry set when it first arrived on the market in 1977 is now the widely available wand. Today, dozens of different devices promise to promptly deliver what any possibly-pregnant person is assumed to want: knowledge of her status.
Now a new study suggests that for all of the ease and convenience of the at-home test, a significant number of women would prefer not to know. Given the choice, they would opt instead to take two drugs approved by the Food and Drug Administration to terminate a pregnancy. The first drug, mifepristone, blocks the effects of progesterone, a hormone without which the lining of the uterus begins to break down, while the second drug, misoprostol, induces contractions of the uterus that expel its contents.